Bisphosphonate treatment of children and adults with osteogenesis imperfecta: unanswered questions.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26071113.
- Also identified by DOI 10.1007/s00223-015-0021-6.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bisphosphonates are extensively used for treatment of children and adults with osteogenesis imperfecta. Over years, studies have reported the response of BP treatment in individuals with OI but some questions remain still unanswered.
Medical subject headings
- Bone Density Conservation Agents
- Diphosphonates
- Osteogenesis Imperfecta